1. Home
  2. POAI vs PRSO Comparison

POAI vs PRSO Comparison

Compare POAI & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • PRSO
  • Stock Information
  • Founded
  • POAI 2002
  • PRSO 2008
  • Country
  • POAI United States
  • PRSO United States
  • Employees
  • POAI N/A
  • PRSO N/A
  • Industry
  • POAI Industrial Specialties
  • PRSO Semiconductors
  • Sector
  • POAI Health Care
  • PRSO Technology
  • Exchange
  • POAI Nasdaq
  • PRSO Nasdaq
  • Market Cap
  • POAI 4.9M
  • PRSO 4.2M
  • IPO Year
  • POAI N/A
  • PRSO 2001
  • Fundamental
  • Price
  • POAI $0.69
  • PRSO $0.83
  • Analyst Decision
  • POAI Hold
  • PRSO Strong Buy
  • Analyst Count
  • POAI 1
  • PRSO 2
  • Target Price
  • POAI N/A
  • PRSO $3.38
  • AVG Volume (30 Days)
  • POAI 119.5K
  • PRSO 338.3K
  • Earning Date
  • POAI 11-12-2024
  • PRSO 11-12-2024
  • Dividend Yield
  • POAI N/A
  • PRSO N/A
  • EPS Growth
  • POAI N/A
  • PRSO N/A
  • EPS
  • POAI N/A
  • PRSO N/A
  • Revenue
  • POAI $1,484,223.00
  • PRSO $12,727,000.00
  • Revenue This Year
  • POAI N/A
  • PRSO $17.49
  • Revenue Next Year
  • POAI $502.91
  • PRSO $0.67
  • P/E Ratio
  • POAI N/A
  • PRSO N/A
  • Revenue Growth
  • POAI N/A
  • PRSO N/A
  • 52 Week Low
  • POAI $0.55
  • PRSO $0.73
  • 52 Week High
  • POAI $3.76
  • PRSO $11.20
  • Technical
  • Relative Strength Index (RSI)
  • POAI 44.88
  • PRSO 29.83
  • Support Level
  • POAI $0.70
  • PRSO $0.92
  • Resistance Level
  • POAI $0.89
  • PRSO $1.17
  • Average True Range (ATR)
  • POAI 0.11
  • PRSO 0.23
  • MACD
  • POAI 0.00
  • PRSO -0.10
  • Stochastic Oscillator
  • POAI 14.64
  • PRSO 6.83

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: